Asian Tribune Your Multilingual Newspaper covering World and local news News
An expert panel of India’s Central Drug Authority on Tuesday recommended granting permission to Serum Institute of India (SII) for conducting phase 2/3 trials of Covovax on children aged 2 to 17 years with certain conditions, official sources said. The trials would cover 920 children, 460 each in the age-group …
Read More »Expert panel recommends nod to SII for phase 2/3 trials of Covovax on children aged 2-17
